Menu

Stock Market Live: Gift Nifty indicates flat start for Sensex, Nifty

Shares of Anthem Biosciences, a contract research, development, and manufacturing organisation (CRDMO), made a strong debut on the domestic bourses on Monday, undermining weakness in the broader market. The stock listed at ₹723.05 on the National Stock Exchange (NSE), marking a 26.85% premium over its initial public offering (IPO) price of ₹570 per share. On the BSE, shares debuted at ₹723.10, up 26.86%, taking the company’s market capitalisation to ₹40,610 crore.

Related Posts

Back To Top
the Ivy

The Ivy is our flagship newsletter delivered 3x per week (Mon, Wed, Fri) with a focus on investments that can stand the test of time. Investors who seek undervalued companies, passive income, or top-rated ETFs will find The Ivy to be the definitive financial newsletter.

the Burst

If you trade the markets seeking to find the next growth stock, The Burst was created for you. In this newsletter (delivered Tue/Thu), we spotlight companies that are changing the world as well as cryptocurrencies and blockchain projects disrupting the status quo.

the Spotlight

In our weekly Spotlight newsletter, we shine a light on “stand-out” companies that have high potential. You will also find an assortment of “big picture” topics covered, from economic insights to stock market outlook.

the Daily

We aggregate some of the best up to date investing stories and news from around the web and deliver it to you each day in The Daily.

Enter your email to join the tens of thousands of traders and investors already taking advantage of the complimentary Summa Money newsletters


© Summa Money 2025
Powered by WordPress • Themify WordPress Themes